Karl Leibinger Medizintechnik GmbH & Co. KG
Karl Leibinger Medizintechnik GmbH & Co. KG, commonly known as KLS Martin, is a leading player in the medical technology industry, headquartered in Tuttlingen, Germany. Founded in 1923, the company has established itself as a pioneer in the development of innovative surgical instruments and implants, particularly in the fields of cranio-maxillofacial surgery and orthopaedics. With a strong presence in Europe and expanding operations globally, KLS Martin is renowned for its high-quality products, including advanced surgical systems and customised solutions that enhance surgical precision and patient outcomes. The company’s commitment to research and development has led to numerous milestones, solidifying its position as a trusted partner for healthcare professionals. KLS Martin's dedication to excellence and innovation continues to drive its success in the competitive medical technology landscape.
DitchCarbon Score
How does Karl Leibinger Medizintechnik GmbH & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Karl Leibinger Medizintechnik GmbH & Co. KG's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Karl Leibinger Medizintechnik GmbH & Co. KG's reported carbon emissions
Karl Leibinger Medizintechnik GmbH & Co. KG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, it appears that Karl Leibinger Medizintechnik may not have established formal commitments to reduce carbon emissions or participate in industry-standard initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the medical technology industry, companies are increasingly recognising the importance of sustainability and climate action. However, without specific data or commitments, it is unclear how Karl Leibinger Medizintechnik aligns with these broader industry trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Karl Leibinger Medizintechnik GmbH & Co. KG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
